Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07672483 IL-12 Genetically Engineered Myeloid Cells in Participants With Relapse… |
IL-12 GEMys | Cancer | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-10-07 → 2029-01-15 | Ouvrir |
| NCT06694454 Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Du… |
azacytidine | Cancer | Phase 1/2 | SUSPENDED | En attente / non publié | National Cancer Institute (NCI) | United States · National Institutes of Health Clinica… | 2026-10-07 → 2034-12-31 | Ouvrir |
| NCT05673148 Testing the Addition of Total Ablative Therapy to Usual Systemic Therap… |
Stereotactic Ablative Radiotherapy | Cancer | Phase 2 | RECRUITING | En attente / non publié | Alliance for Clinical Trials in O… | United States, Canada · Allegheny General Hospital, P… | 2023-10-09 → 2032-08-12 | Ouvrir |
| NCT03821623 Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and… |
Nicotinamide riboside | Hypertension | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Douglas Seals | United States · Integrative Physiology of Aging Labor… | 2019-05-10 → 2027-10-01 | Ouvrir |
| NCT07067632 HTN-Mort — Mortality Outcome of Controlled Blood Pressure Participants |
Antihypertensive treatment | Hypertension | À vérifier | COMPLETED | En attente / non publié | DejthidaNathaphong | Thailand · Nathaphong, Bangkok, Thailand | 2025-07-01 → 2026-09-29 | Ouvrir |
| NCT07142356 A Study of Modified Release RTN-001 In Patients With Uncontrolled Hyper… |
RTN-001 | Hypertension | Phase 2 | RECRUITING | En attente / non publié | Retension Pharmaceuticals. Inc. | United States · CRO Call Center, Decatur, United Stat… | 2025-10-31 → 2027-06 | Ouvrir |
| NCT06995729 A Study to Learn About the Study Medicine Called Zavegepant (PF-0793020… |
Zavegepant | Migraine | Phase 1 | RECRUITING | En attente / non publié | University of South Florida | United States · Accellacare - Piedmont, Statesville, … | 2025-05-16 → 2027-08-12 | Ouvrir |
| NCT06584409 Migraines Accepted Laser Acupuncture Compared in Blood Test of MMP2 and… |
Laser Pen | Migraine | Non applicable | RECRUITING | En attente / non publié | Taichung Veterans General Hospital | Taiwan · Taichung Veterans General Hospital, Taichung… | 2025-04-07 → 2027-12-01 | Ouvrir |
| NCT06428838 Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute … |
Eptinezumab | Migraine | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | H. Lundbeck A/S | Canada · Royal Columbian Hospital, New Westminster, C… | 2025-05-05 → 2028-03 | Ouvrir |
| NCT07849283 Efficacy of Cognitive Behavioral Therapy at Vestibular Migraine |
•Group A: Patients will receive M… | Migraine | Non applicable | NOT_YET_RECRUITING | En attente / non publié | Sohag University | Egypt · Sohag University, Sohag, Egypt | 2026-11 → 2027-03 | Ouvrir |
| NCT07856056 Nortriptyline Compared With Amitriptyline for Migraine Prevention at SQ… |
Nortriptyline | Migraine | Phase 4 | NOT_YET_RECRUITING | En attente / non publié | Sultan Qaboos University | Oman · Sultan Qaboos University Hospital, University … | 2027-05 → 2030-12 | Ouvrir |
| NCT05156398 Efficacy and Safety Study of Rimegepant for the Preventative Treatment … |
Rimegepant | Migraine | Phase 3 | RECRUITING | En attente / non publié | University of South Florida | United States, Canada, France, Italy, Japan, Poland, … | 2022-02-28 → 2032-10-30 | Ouvrir |
| NCT07616128 Study of EVO756 in Adults With Migraine |
EVO756, Dose 1 | Migraine | Phase 2 | RECRUITING | En attente / non publié | Evommune, Inc. | United States, Canada, New Zealand · Accel Research S… | 2026-07-29 → 2027-11 | Ouvrir |
| NCT06769659 A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years… |
NPT 2042 | Épilepsie | Phase 2 | COMPLETED | En attente / non publié | NeuroPro Therapeutics, Inc. | United States · Clinical Trials, Inc. (CTI), Little R… | 2025-03-11 → 2026-09-23 | Ouvrir |
| NCT04653012 EpiMicro — Multi-level Approach of Brain Activity Using Intracranial El… |
Intracranial macro-microelectrode… | Épilepsie | Non applicable | RECRUITING | En attente / non publié | Institut National de la Santé Et … | France · Hôpital de la Salpêtrière, Paris, France | 2021-02-28 → 2031-02-27 | Ouvrir |
| NCT05232630 FENDEEP — Fenfluramine for the Treatment of Different Types of Developm… |
fenfluramine | Épilepsie | Phase 4 | COMPLETED | En attente / non publié | Hospital Ruber Internacional | Spain · Hospital Ruber Internacional, Madrid, Spain | 2022-10-20 → 2024-12-31 | Ouvrir |
| NCT07680322 Safety and Efficacy of AV078 in Participants With Tuberous Sclerosis Co… |
AV078 | Épilepsie | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Aeovian Pharmaceuticals, Inc. | Canada · London Health Sciences Centre, London, Canada | 2026-09-01 → 2027-12-21 | Ouvrir |
| NCT07228338 Cholinergic Enhancement of Theta |
COBENFY KarXT (50/20 mg) | Épilepsie | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | University of Texas Southwestern … | United States · University of Texas Southwestern Medi… | 2026-12 → 2031-12 | Ouvrir |
| NCT07847918 A Fully Remote Feasibility Trial of Phenylbutyrate for SLC6A1-Related D… |
Glycerol Phenylbutyrate | Épilepsie | Phase 2 | RECRUITING | En attente / non publié | Scripps Translational Science Ins… | United States · Scripps Research Translational Instit… | 2026-10 → 2032-10 | Ouvrir |
| NCT07520955 SLEEP-TIES — Lily's Grace Temporal Interference |
TES-TI | Épilepsie | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of Wisconsin, Madison | United States · UW School of Medicine and Public Heal… | 2026-10 → 2028-09 | Ouvrir |
| NCT02531880 Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic… |
Mangafodipir | Épilepsie | Phase 1 | RECRUITING | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2024-11-19 → 2030-07-01 | Ouvrir |
| NCT00060541 Evaluation and Treatment of Neurosurgical Disorders |
Laboratory tests | Épilepsie | À vérifier | RECRUITING | En attente / non publié | National Institute of Neurologica… | United States · National Institutes of Health Clinica… | 2003-06-04 | Ouvrir |
| NCT06798896 RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study … |
SPN-817 | Épilepsie | Phase 2 | RECRUITING | En attente / non publié | Supernus Pharmaceuticals, Inc. | United States, Australia, Bulgaria, Hungary, Poland ·… | 2024-12-30 → 2027-08 | Ouvrir |
| NCT05104983 TSC-STEPS — Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilep… |
Sirolimus | Épilepsie | Phase 2 | RECRUITING | En attente / non publié | Darcy Krueger | United States · Boston Children's Hospital, Boston, U… | 2021-10-13 → 2028-06-30 | Ouvrir |
| NCT06038929 Effect of Vagal Nerve Stimulation on Gastric Motor Functions |
Vagal nerve stimulant | Épilepsie | Non applicable | RECRUITING | En attente / non publié | Mayo Clinic | United States · Mayo Clinic in Rochester, Rochester, … | 2025-09-01 → 2027-12-30 | Ouvrir |